ARCHIVES

Genetronics Phase II Trials For Head & Neck Completed.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991